CLINICAL EFFICACY OF DEEP BRAIN STIMULATION (DBS) IN PARKINSON’S DISEASE
Keywords:
Parkinson’s disease, DBS, deep brain stimulation, motor symptoms, quality of lifeAbstract
This article analyzes the clinical efficacy of Deep Brain Stimulation (DBS) in Parkinson’s disease. The study evaluates motor symptoms, quality of life, reduction in dopaminergic therapy requirements, and side effects in two groups: 30 patients who underwent DBS treatment at Medipol University Hospital in Istanbul, Turkey, and 30 patients treated only with pharmacotherapy at Tashkent Medical Academy. The findings revealed that DBS significantly reduces motor symptoms, improves quality of life, decreases the need for medications, and may cause certain side effects in some cases.
References
Deuschl G., Agid Y. Subthalamic stimulation for Parkinson’s disease with early fluctuations: A 5-year follow-up. Lancet Neurology, 2018.
Dorsey, E. R., Scherer, T., Okun, M. S., & Bloem, B. R. (2020). The emerging evidence of the Parkinson pandemic. Journal of Parkinson’s Disease, 10(s1), S3–S8.
Feigin, V. L., Vos, T., Alahdab, F., et al. (2023). Global burden of neurological disorders: A systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology, 22(1), 30–55.
Krause M. et al. Deep brain stimulation for Parkinson’s disease: long-term outcomes. Brain, 2020.
Okun M.S. et al. Selecting DBS Candidates: Clinical Guidelines. Movement Disorders, 2022.
Poewe W. et al. Parkinson disease. Nature Reviews Disease Primers, 2023.
Schuepbach W.M.M. et al. Neurostimulation for Parkinson’s disease with early motor complications. New England Journal of Medicine, 2022.
Khaydarova D.K., Mansurova N.A. Analysis of Motor Complications in Parkinson’s Disease Phenotypes. Journal of Advances in Medicine and Medical Research. 25(5): 1-7, 2018;
Yang, T. T., Liu, C. G., Gao, S. C., Zhang, Y., & Wang, P. C. (2018). The serum exosome-derived microRNA-135a, -193b, and -384 were potential Alzheimer’s disease biomarkers. Biomedical and Environmental Sciences, 31(2), 87–96.
